ACT/Albuquerque Clinical Trials is an independent clinical research organization.  ACT works in conjunction with RGFM, which is a private, outpatient care center.  In addition, we are affiliated with First Choice Community Healthcare, a primary healthcare system serving over 40,000 patients.  Our site has been conducting phase II-IV pharmaceutical studies since 1989.    We strive to exceed enrollment requirements, adhere strictly to protocol guidelines and provide accurate data in a timely, cost effective manner.  We emphasize the use of good clinical practice to meet the needs of each sponsor.

We contract with physicians and dentists in various subspecialties, including: Cardiology, Gastroenterology, Rheumatology, ENT, Podiatry, Allergy and Immunology, and dentistry.

We have worked with the following sponsors and CRO's: Glaxo Wellcome, SmithKline Beecham, Merck & Co., Novartis, Pfizer, Parke Davis, Ciba-Geigy, Sandoz, ViroPharma, Quintiles, PPD Pharmaco, Clinitrials, Innapharma, FACT, Covancem Bristol-Myers Squibb, Bayer, Solvay, Covance, Searle, Pharmacia/Upjohn, GlaxoSmithKline, Parexel, PRA, Scirex, Premier, MTRA, Innovex and Upjohn.